188 related articles for article (PubMed ID: 7910953)
1. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis.
Christofori G; Naik P; Hanahan D
Nature; 1994 Jun; 369(6479):414-8. PubMed ID: 7910953
[TBL] [Abstract][Full Text] [Related]
2. Impairment of survival factor function potentiates chemotherapy-induced apoptosis in tumor cells.
Lamm GM; Christofori G
Cancer Res; 1998 Feb; 58(4):801-7. PubMed ID: 9485038
[TBL] [Abstract][Full Text] [Related]
3. An insulin-like growth factor-mediated, phosphatidylinositol 3' kinase-independent survival signaling pathway in beta tumor cells.
Burtscher I; Compagni A; Lamm GM; Christofori G
Cancer Res; 1999 Aug; 59(16):3923-6. PubMed ID: 10463584
[TBL] [Abstract][Full Text] [Related]
4. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.
Liu P; Terradillos O; Renard CA; Feldmann G; Buendia MA; Bernuau D
Hepatology; 1997 Apr; 25(4):874-83. PubMed ID: 9096591
[TBL] [Abstract][Full Text] [Related]
5. Oncogene-induced up-regulation of Caco-2 cell proliferation involves IGF-II gene activation through a protein kinase C-mediated pathway.
Cadoret A; Baron-Delage S; Bertrand F; Kornprost M; Groyer A; Gespach C; Capeau J; Cherqui G
Oncogene; 1998 Aug; 17(7):877-87. PubMed ID: 9780004
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of both imprinted and expressed alleles of the insulin-like growth factor 2 gene during beta-cell tumorigenesis.
Christofori G; Naik P; Hanahan D
Nat Genet; 1995 Jun; 10(2):196-201. PubMed ID: 7663515
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic co-operation in beta-cell tumorigenesis.
Pelengaris S; Khan M
Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
[TBL] [Abstract][Full Text] [Related]
8. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia.
Petrik J; Pell JM; Arany E; McDonald TJ; Dean WL; Reik W; Hill DJ
Endocrinology; 1999 May; 140(5):2353-63. PubMed ID: 10218989
[TBL] [Abstract][Full Text] [Related]
10. TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis.
Müller-Hermelink N; Braumüller H; Pichler B; Wieder T; Mailhammer R; Schaak K; Ghoreschi K; Yazdi A; Haubner R; Sander CA; Mocikat R; Schwaiger M; Förster I; Huss R; Weber WA; Kneilling M; Röcken M
Cancer Cell; 2008 Jun; 13(6):507-18. PubMed ID: 18538734
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor II is focally up-regulated and functionally involved as a second signal for oncogene-induced tumorigenesis.
Naik P; Christofori G; Hanahan D
Cold Spring Harb Symp Quant Biol; 1994; 59():459-70. PubMed ID: 7587100
[No Abstract] [Full Text] [Related]
14. Generation and characterization of islet cell tumor in pTet-on/pTRE-SV40Tag double-transgenic mice model.
Shen Q; Sun Q; Wei X; Dong J; Zhang R; Wu P; Jin Y; Feng J; Li H; Hu Y
J Biosci Bioeng; 2007 Jul; 104(1):14-21. PubMed ID: 17697978
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of MHC class I antigen in insulinoma cells controlled by the R1 element of the H-2 enhancer.
Ye X; Kralli A; Ge R; Ricciardi RP; Knowles BB
Oncogene; 1994 Apr; 9(4):1195-204. PubMed ID: 8134122
[TBL] [Abstract][Full Text] [Related]
16. WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis.
Li M; Lewis B; Capuco AV; Laucirica R; Furth PA
Oncogene; 2000 Feb; 19(8):1010-9. PubMed ID: 10713684
[TBL] [Abstract][Full Text] [Related]
17. Expression of a viral oncoprotein during mammary gland development alters cell fate and function: induction of p53-independent apoptosis is followed by impaired milk protein production in surviving cells.
Li M; Hu J; Heermeier K; Hennighausen L; Furth PA
Cell Growth Differ; 1996 Jan; 7(1):3-11. PubMed ID: 8788028
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes.
Ganss R; Hanahan D
Cancer Res; 1998 Oct; 58(20):4673-81. PubMed ID: 9788621
[TBL] [Abstract][Full Text] [Related]
19. Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth.
Schirmacher P; Held WA; Yang D; Chisari FV; Rustum Y; Rogler CE
Cancer Res; 1992 May; 52(9):2549-56. PubMed ID: 1568224
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyoblast apoptosis induced by insulin-like growth factor (IGF)-I resistance is IGF-II dependent and synergistically enhanced by angiotensin II.
Kuo WW; Liu CJ; Chen LM; Wu CH; Chu CH; Liu JY; Lu MC; Lin JA; Lee SD; Huang CY
Apoptosis; 2006 Jul; 11(7):1075-89. PubMed ID: 16699953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
